{
    "medicine_id": "ae591bc604e55d5dbe48090a37efcf2de0f3ad83",
    "platform_id": "DB10401",
    "metadata": {
        "name": "Acarizax 12 SQ HDM Powder",
        "composition": "12 SQ HDM Dermatophagoides pteronyssinus",
        "clinical_particulars": {
            "therapeutic_indications": "Dermatophagoides pteronyssinus is an allergen extract indicated as immunotherapy for house dust mite HDM induced allergic rhinitis with or without conjunctivitis confirmed by in vitro testing for IgE antibodies to Dermatophagoides pteronyssinus house dust mites or skin testing to licensed house dust mite allergen extracts Dermatophagoides pteronyssinus is approved for use in adults 18 through 65 years of age",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Treatment with ACTAIR has been shown to induce a systemic antibody response towards house dust mite allergens with an increase in specific IgG4 antibodies in some patients These immunoglobulins may compete with IgE for allergen binding thereby decreasing allergen capture and presentation",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}